Trinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry
DUBLIN, Ireland, Jan. 09, 2023 (GLOBE NEWSWIRE) — Trinity Biotech (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced a strategic partnership with imaware Inc that combines their built-to-partner digital health platform with Trinity Biotech’s advanced reference laboratory facilities to power the Digital Health Industry with at-home and remote testing programs.
Related news for (TRIB)
- Powering Into the Close: Biotech and Blockchain Light Up Late Session
- Midday Movers: Biotech Gets Bold- From Fentanyl Defense to Tokenized Stem Cells
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/20/25 09:00 AM
- Gene Therapy, Global Patents & Cancer Innovation: Biopharma Heats Up as Trials Restart and Tech Advances
- Today’s Top Performers: MoBot’s Market Review 08/14/25 10:00 AM